Evaluate changes in tear film osmolarity and other DED signs/symptoms following treatment with IPL.
Prospective study design among subjects with MGD and qualifying for IPL therapy. Study testing done at baseline visit when subjects are scheduled for IPL therapy. Measurements will be made on day 15 (prior to second IPL sitting), Day 45 (prior to third IPL setting), Day 75 (fourth IPL setting) and Day 105 as needed (30 days after IPL setting 4). Subjects willing to come for follow up visits as scheduled and may not have instilled any artificial tears 2 hours prior to study measurements. No history of ocular infection or corneal degeneration/dystrophy No history of corneal refractive surgery and/or change in ocular medications in the last 2 months
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
60
Tear film osmolarity change
Time frame: Measurements will be made on day 15 (prior to second IPL sitting), Day 45 (prior to third IPL setting), Day 75 (fourth IPL setting) and Day 105 as needed (30 days after IPL setting 4).
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.